Financial Performance - The company's operating revenue for Q1 2025 was ¥1,063,046,542.03, representing a 27.85% increase compared to ¥831,488,119.72 in the same period last year[4] - Net profit attributable to shareholders decreased by 37.00% to ¥13,608,124.12 from ¥21,599,522.11 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥13,247,504.42, down 23.95% from ¥17,419,299.81 in the previous year[4] - The weighted average return on equity decreased to 0.63% from 1.03% year-on-year, reflecting a decline in profitability[4] - The company reported a basic earnings per share of ¥0.037, down 48.61% from ¥0.072 in the same period last year[4] - Net profit for the current period was ¥16,309,582.59, a decrease of 4.7% from ¥17,120,525.90 in the previous period[20] - The company reported a total profit of ¥27,585,000.60, down from ¥30,664,582.52 in the previous period[20] - Other comprehensive income after tax for the current period was ¥425,381.25, down from ¥1,345,665.56 in the previous period[20] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥41,346,445.10, a decline of 61.15% compared to -¥25,657,489.56 in the same period last year[4] - Cash flow from operating activities showed a net outflow of approximately 41.3 million, a decrease of 61.15% year-on-year, attributed to reduced net profit and increased inventory[9] - Cash and cash equivalents at the end of the period decreased by 35.15% to approximately 398.9 million, primarily due to a significant reduction in the beginning cash balance[10] - The company experienced a net cash flow from financing activities of ¥234,197,365.90, a significant improvement from -¥206,155,786.00 in the previous period[22] Assets and Liabilities - Total assets increased by 9.24% to ¥3,354,995,352.71 from ¥3,071,313,954.39 at the end of the previous year[4] - Total current liabilities increased by 32.79% to approximately 874 million, primarily due to an increase in short-term bank loans[9] - Total liabilities increased by 32.12% to approximately 1.056 billion, primarily due to an increase in bank loans[9] - The company's total liabilities increased to CNY 1,056,145,479.73 from CNY 799,354,245.41, representing a rise of approximately 32.2%[16] - The company's total liabilities to equity ratio increased, reflecting a higher leverage position compared to the previous period[16] Inventory and Borrowings - Inventory levels increased by 58.22% to ¥276,917,288.17, attributed to stockpiling of raw materials and finished goods before periodic maintenance[8] - Short-term borrowings surged by 158.26% to ¥309,355,303.06, mainly due to an increase in short-term bank loans[8] - Short-term borrowings rose significantly to CNY 309,355,303.06 from CNY 119,783,804.45, marking an increase of approximately 158.5%[16] - The company's inventory increased to CNY 276,917,288.17 from CNY 175,022,395.76, reflecting a growth of approximately 58.3%[15] Investment and Research - Investment cash outflow decreased by 72.68% to approximately 69.8 million, mainly due to reduced project construction funding[10] - Research and development expenses increased to ¥13,218,939.65, compared to ¥11,442,222.93 in the prior period, reflecting a focus on innovation[19] Shareholder Information - The number of common shareholders at the end of the reporting period was 22,331[12] - The total equity attributable to the parent company reached CNY 2,172,884,066.30, up from CNY 2,149,780,588.96, indicating an increase of about 1.07%[17]

Core Viewpoint - Yueyang Xinchang (000819) reported a revenue of 1.063 billion yuan in the first quarter of 2025, reflecting a year-on-year growth of 27.85%. However, the net profit decreased to 13.6081 million yuan, representing a decline of 37.00% compared to the previous year [1]. Financial Performance - The company's revenue for Q1 2025 reached 1.063 billion yuan, marking a 27.85% increase year-on-year [1]. - The net profit for the same period was 13.6081 million yuan, which is a 37.00% decrease year-on-year [1].

Company Overview - Yueyang Xingchang's closing price on April 16 was 14.53 yuan, with an increase of 1.96%, resulting in a rolling PE ratio of 85.10 times and a total market value of 5.372 billion yuan [1] - The company's main business includes the development, production, and sales of chemical new materials, energy conservation and environmental protection, and petrochemical products, with key products such as methyl tert-butyl ether, liquefied petroleum gas, propylene, industrial isooctane, and calcined petroleum coke [1] Financial Performance - For the latest fiscal year 2024, the company reported an operating income of 3.823 billion yuan, representing a year-on-year increase of 24.62%, while net profit was 631.256 million yuan, showing a year-on-year decrease of 37.55%, with a sales gross margin of 17.73% [1] Industry Comparison - In the context of the petroleum industry, Yueyang Xingchang's PE ratio of 85.10 is significantly higher than the industry average of 11.53 and the industry median of 33.65, placing the company at the 18th position in the industry ranking [2] - The overall capital flow for Yueyang Xingchang on April 16 showed a net inflow of 18.1515 million yuan, although the company experienced a total outflow of 3.0858 million yuan over the past five days [1]

Group 1 - The company received a government subsidy of 12,570,000.00 yuan, which accounts for 19.91% of the latest audited net profit attributable to shareholders [2] - The subsidy is related to the company's daily operations and is not sustainable [2] - The subsidy will cumulatively impact the company's profit total for the current and future accounting periods by 12,570,000.00 yuan, with specific accounting treatment pending annual audit confirmation [5] Group 2 - The type of subsidy is classified under government grants, which can be either asset-related or income-related according to accounting standards [3] - The government subsidy will be recognized as deferred income amounting to 12,570,000.00 yuan [4]

岳阳兴长关于获得政府补助的公告 证券代码：000819 证券简称：岳阳兴长 公告编号：2025-014 岳阳兴长石化股份有限公司 关于获得政府补助的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、 获得补助的基本情况 公司近日收到政府补助 12,570,000.00 元，占公司最近一期经审计归属于上市公司 股东净利润的 19.91%。该补助与公司日常经营活动相关，不具有可持续性。 二、补助的类型及其对上市公司的影响 1、补助的类型 根据《企业会计准则第 16 号—政府补助》的规定，与资产相关的政府补助， 是指企业取得的、用于构建或以其他方式形成长期资产的政府补助；与收益相关的 政府补助，是指除与资产相关的政府补助之外的政府补助。 2、补助的确认与计量 按照《企业会计准则第 16 号—政府补助》的规定，将上述政府补助计入递延 收益的金额为 12,570,000.00 元。 3、对上市公司的影响 上述政府补助将 累计 影 响 上 市 公司 当期 以 及 未 来 会计 期间 利 润 总 额 12,570,000.00 元，具体的会计处理仍需以会计师事务所年 ...

岳阳兴长（000819）公告，公司近日收到政府补助1257万元，占公司最近一期经审计归属于上市公司股 东净利润的19.91%。该补助与公司日常经营活动相关，不具有可持续性。上述政府补助将累计影响上 市公司当期以及未来会计期间利润总额1257万元。 ...

岳阳兴长石化股份有限公司 关于公司及子公司主体生产装置周期性停工检修的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 岳阳兴长石化股份有限公司（以下简称"公司"）及控股子公司湖南新岭化工 股份有限公司（以下简称"新岭化工"）、惠州立拓新材料有限责任公司（以下简称 "惠州立拓"）主体生产装置于近期陆续停工进行检修，现将有关情况公告如下： 一、装置停工检修情况 公司及新岭化工主体生产装置已按计划连续运行四年，同时惠州立拓上游原料 供应生产装置停工，根据公司检修计划安排，为确保未来各装置继续实现安全、平 稳生产，各装置近日陆续停工进行检修。 公司及新岭化工本次停工检修是装置两个运行周期之间的正常停工检修，主要 目的在于对设备、容器、管线等进行检验、检修、维护和改造，确保下一生产周期 装置本质安全、生产平稳。惠州立拓本次为上游装置停工情况下的陪停检修，检修 期间将根据前期试运行情况，对装置进行检修消缺改造，确保高端产品稳产放量。 岳阳兴长关于公司及子公司主体生产装置周期性停工检修的公告 证券代码：000819 证券简称：岳阳兴长 公告编号：2025-013 岳阳 ...

岳阳兴长石化股份有限公司的主营业务是化工新材料、节能环保、能源化工等石油化工产品的开发、生 产、销售以及成品油零售等业务。公司的主要产品是甲基叔丁基醚、液化石油气、丙烯、工业异辛烷、 邻甲酚、煅后石油焦、特种聚丙烯。 最新一期业绩显示，2024年年报，公司实现营业收入38.23亿元，同比24.62%；净利润6312.56万元，同 比-37.55%，销售毛利率17.73%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)18岳阳兴长94.2394.232.7759.48亿行业平均 12.1812.351.251729.78亿行业中值43.5869.811.6959.48亿1中晟高科-13.21-14.425.7522.29亿2茂化实 华-9.58-14.402.9618.40亿3沈阳化工-8.33-6.122.0528.03亿4国际实业-5.94-5.941.2926.05亿5华锦股 份-5.45110.570.6377.73亿6*ST海越-4.99-5.760.4914.14亿7博汇股份-4.02-9.823.7619.93亿8ST新潮 6.706.130.74159.13亿9洲际油气7.147.68 ...

3月31日晚间，岳阳兴长（000819）石化股份有限公司(以下简称"岳阳兴长")发布2024年年度报告。尽 管面临复杂多变的行业环境，公司全年实现营业总收入38.23亿元，同比增长24.62%，展现出强劲的市 场拓展能力。与此同时，公司在新材料领域的研发投入和高端产品布局取得积极进展，为中长期高质量 发展奠定基础。 年报显示，岳阳兴长2024年营业收入增速在石油加工贸易行业中位居前列，增长主要得益于石油加工和 化工产品的销售增长。 值得注意的是，2024年，岳阳兴长研发总投入达7253.89万元，同比增长32.32%，实现连续四年增长， 研发投入占比提升至1.90%。这一投入力度在近五年同期中排名第一，推动多项技术攻关取得实质性进 展。 特别是在高端聚烯烃领域，岳阳兴长旗下的茂金属聚丙烯催化剂技术研发成功，填补国内空白，相关产 品已进入试生产阶段，预计将打破进口依赖，抢占新能源汽车轻量化材料市场。 同时，在绿色化工方面，岳阳兴长开发的生物基聚烯烃产品通过国际环保认证，为欧盟市场准入铺平道 路。此外，岳阳兴长也在大力推动特种酚产业化发展，旗下的间对甲酚项目完成试生产，产品纯度达 99.9%，可广泛应用于医药、农 ...

中信建投证券股份有限公司 关于岳阳兴长石化股份有限公司 2024 年度募集资金存放与使用情况的核查意见 中信建投证券股份有限公司（ 以下简称"中信建投"或"保荐人"）作为岳 阳兴长石化股份有限公司 以下简称"岳阳兴长"或"公司"）2022 年度向特 定对象发行股票的保荐人，根据《证券发行上市保荐业务管理办法》《上市公司 监管指引第 2 号—上市公司募集资金管理和使用的监管要求》《深圳证券交易所 股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号—主板上市公司 规范运作》（《深圳证券交易所上市公司自律监管指引第 13 号—保荐业务》等有关 法律法规和规范性文件的要求，对岳阳兴长 2024 年度募集资金存放与使用情况 进行了审慎核查，具体核查情况如下： 一、募集资金基本情况 一）募集资金到位情况 根据中国证券监督管理委员会出具的 《关于同意岳阳兴长石化股份有限公 司向特定对象发行股票注册的批复》证监许可（ 2023〕2054 号），公司向特定对 象发行人民币普通股（ A 股）61,616,251 股，募集资金总额为人民币 973,536,765.80 元，募集资金净额为人民币 962,098,086.5 ...